NO782539L - Fremgangsmaate ved fremstilling av prostaglandinantagonistiske forbindelser - Google Patents
Fremgangsmaate ved fremstilling av prostaglandinantagonistiske forbindelserInfo
- Publication number
- NO782539L NO782539L NO782539A NO782539A NO782539L NO 782539 L NO782539 L NO 782539L NO 782539 A NO782539 A NO 782539A NO 782539 A NO782539 A NO 782539A NO 782539 L NO782539 L NO 782539L
- Authority
- NO
- Norway
- Prior art keywords
- thiepine
- acid
- mixture
- carboxylic acid
- dihydro
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims description 54
- 238000000034 method Methods 0.000 title claims description 24
- -1 C-^ - C4 -alkanoyl Chemical group 0.000 claims description 43
- 239000002253 acid Substances 0.000 claims description 42
- 239000000460 chlorine Substances 0.000 claims description 14
- 125000000217 alkyl group Chemical group 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 9
- 229910052794 bromium Inorganic materials 0.000 claims description 8
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 claims description 8
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 7
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 7
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 5
- 229910052801 chlorine Inorganic materials 0.000 claims description 5
- IVRMZWNICZWHMI-UHFFFAOYSA-N Azide Chemical compound [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 3
- 239000011737 fluorine Substances 0.000 claims description 3
- 229910052731 fluorine Inorganic materials 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical group 0.000 claims description 3
- 150000002431 hydrogen Chemical group 0.000 claims description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 3
- 125000005034 trifluormethylthio group Chemical group FC(S*)(F)F 0.000 claims description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 3
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims description 2
- 125000003396 thiol group Chemical class [H]S* 0.000 claims 1
- 239000000203 mixture Substances 0.000 description 96
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 89
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 81
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 75
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 73
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 72
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 71
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 62
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 57
- 239000000243 solution Substances 0.000 description 56
- 239000007787 solid Substances 0.000 description 55
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 50
- 239000000047 product Substances 0.000 description 46
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 44
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 42
- 238000002844 melting Methods 0.000 description 42
- 230000008018 melting Effects 0.000 description 42
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 39
- 239000011541 reaction mixture Substances 0.000 description 34
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 33
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 32
- 229960000583 acetic acid Drugs 0.000 description 31
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 28
- 238000006243 chemical reaction Methods 0.000 description 26
- 239000000741 silica gel Substances 0.000 description 23
- 229910002027 silica gel Inorganic materials 0.000 description 23
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 22
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 22
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 20
- UZVGSSNIUNSOFA-UHFFFAOYSA-N dibenzofuran-1-carboxylic acid Chemical compound O1C2=CC=CC=C2C2=C1C=CC=C2C(=O)O UZVGSSNIUNSOFA-UHFFFAOYSA-N 0.000 description 19
- 239000007858 starting material Substances 0.000 description 19
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 18
- 238000010992 reflux Methods 0.000 description 18
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 17
- 239000000284 extract Substances 0.000 description 16
- 238000001914 filtration Methods 0.000 description 15
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 14
- 150000003180 prostaglandins Chemical class 0.000 description 13
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 12
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 12
- 239000000706 filtrate Substances 0.000 description 12
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 11
- 208000006673 asthma Diseases 0.000 description 11
- 239000002585 base Substances 0.000 description 11
- 238000003756 stirring Methods 0.000 description 11
- 150000003536 tetrazoles Chemical class 0.000 description 11
- 125000005431 alkyl carboxamide group Chemical group 0.000 description 10
- 125000005907 alkyl ester group Chemical group 0.000 description 10
- 229910052500 inorganic mineral Inorganic materials 0.000 description 10
- 235000010755 mineral Nutrition 0.000 description 10
- 239000011707 mineral Substances 0.000 description 10
- YOUSMYQBLMLPTA-UHFFFAOYSA-N 5,6-dihydrobenzo[b][1]benzothiepine-2-carboxylic acid Chemical compound C1CC2=CC=CC=C2SC2=CC(C(=O)O)=CC=C21 YOUSMYQBLMLPTA-UHFFFAOYSA-N 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 229910021529 ammonia Inorganic materials 0.000 description 9
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 9
- 239000000543 intermediate Substances 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 9
- 229910052938 sodium sulfate Inorganic materials 0.000 description 9
- 235000011152 sodium sulphate Nutrition 0.000 description 9
- 150000003462 sulfoxides Chemical class 0.000 description 9
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 8
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 8
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 8
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 8
- 239000000920 calcium hydroxide Substances 0.000 description 8
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 8
- 238000010828 elution Methods 0.000 description 8
- 239000012044 organic layer Substances 0.000 description 8
- 150000003551 thiepines Chemical class 0.000 description 8
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 7
- 125000003545 alkoxy group Chemical group 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 150000003457 sulfones Chemical class 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 6
- 125000003282 alkyl amino group Chemical group 0.000 description 6
- 239000000908 ammonium hydroxide Substances 0.000 description 6
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 6
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 6
- 238000003776 cleavage reaction Methods 0.000 description 6
- 125000004093 cyano group Chemical group *C#N 0.000 description 6
- 239000012954 diazonium Substances 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- 230000008020 evaporation Effects 0.000 description 6
- 230000007062 hydrolysis Effects 0.000 description 6
- 238000006460 hydrolysis reaction Methods 0.000 description 6
- 150000001451 organic peroxides Chemical class 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 238000006722 reduction reaction Methods 0.000 description 6
- 230000007017 scission Effects 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- 125000001424 substituent group Chemical group 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 5
- WTURFORPERPPRJ-UHFFFAOYSA-N 2-(3-bromophenyl)sulfanylbenzoic acid Chemical compound OC(=O)C1=CC=CC=C1SC1=CC=CC(Br)=C1 WTURFORPERPPRJ-UHFFFAOYSA-N 0.000 description 5
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 5
- HSEYABVKUOFKTN-UHFFFAOYSA-N 5,6-dihydrobenzo[b][1]benzothiepine-2-carbonitrile Chemical compound C1CC2=CC=CC=C2SC2=CC(C#N)=CC=C21 HSEYABVKUOFKTN-UHFFFAOYSA-N 0.000 description 5
- NZJFJZLLNNMMDF-UHFFFAOYSA-N 5-oxo-6h-benzo[b][1]benzothiepine-2-carbonitrile Chemical compound O=C1CC2=CC=CC=C2SC2=CC(C#N)=CC=C12 NZJFJZLLNNMMDF-UHFFFAOYSA-N 0.000 description 5
- XEZFAXAPRGCYCY-UHFFFAOYSA-N 5-oxo-6h-benzo[b][1]benzothiepine-2-carboxylic acid Chemical compound S1C2=CC=CC=C2CC(=O)C2=CC=C(C(=O)O)C=C12 XEZFAXAPRGCYCY-UHFFFAOYSA-N 0.000 description 5
- 230000002378 acidificating effect Effects 0.000 description 5
- 229910052783 alkali metal Inorganic materials 0.000 description 5
- RTZHFJMUQLISHT-UHFFFAOYSA-N benzo[b][1]benzothiepine-2-carbonitrile Chemical compound C1=CC2=CC=CC=C2SC2=CC(C#N)=CC=C21 RTZHFJMUQLISHT-UHFFFAOYSA-N 0.000 description 5
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 5
- 238000004587 chromatography analysis Methods 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 229920006395 saturated elastomer Polymers 0.000 description 5
- 239000012279 sodium borohydride Substances 0.000 description 5
- 229910000033 sodium borohydride Inorganic materials 0.000 description 5
- XBGBDQRWWMSINL-UHFFFAOYSA-N 3-acetyl-5,6-dihydrobenzo[b][1]benzothiepine-9-carboxylic acid Chemical compound C1CC2=CC(C(=O)C)=CC=C2SC2=CC(C(O)=O)=CC=C21 XBGBDQRWWMSINL-UHFFFAOYSA-N 0.000 description 4
- ALRHLSYJTWAHJZ-UHFFFAOYSA-N 3-hydroxypropionic acid Chemical compound OCCC(O)=O ALRHLSYJTWAHJZ-UHFFFAOYSA-N 0.000 description 4
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 4
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 4
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical compound CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 150000003973 alkyl amines Chemical class 0.000 description 4
- 235000019270 ammonium chloride Nutrition 0.000 description 4
- 239000012223 aqueous fraction Substances 0.000 description 4
- 230000001851 biosynthetic effect Effects 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 4
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-O diazynium Chemical compound [NH+]#N IJGRMHOSHXDMSA-UHFFFAOYSA-O 0.000 description 4
- JQVDAXLFBXTEQA-UHFFFAOYSA-N dibutylamine Chemical compound CCCCNCCCC JQVDAXLFBXTEQA-UHFFFAOYSA-N 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 239000012362 glacial acetic acid Substances 0.000 description 4
- 239000005457 ice water Substances 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 150000002825 nitriles Chemical class 0.000 description 4
- 239000012299 nitrogen atmosphere Substances 0.000 description 4
- 150000002978 peroxides Chemical class 0.000 description 4
- 150000004965 peroxy acids Chemical class 0.000 description 4
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 4
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 4
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- BLIYQYHXOQQSGL-UHFFFAOYSA-N 3-acetamido-5,6-dihydrobenzo[b][1]benzothiepine-9-carboxylic acid Chemical compound C1CC2=CC(NC(=O)C)=CC=C2SC2=CC(C(O)=O)=CC=C21 BLIYQYHXOQQSGL-UHFFFAOYSA-N 0.000 description 3
- NTXOTYBYIXQHGB-UHFFFAOYSA-N 3-hydroxybenzo[b][1]benzothiepine-9-carboxylic acid Chemical compound C1=CC2=CC(O)=CC=C2SC2=CC(C(=O)O)=CC=C21 NTXOTYBYIXQHGB-UHFFFAOYSA-N 0.000 description 3
- RJADSWKTSXTZJF-UHFFFAOYSA-N 5-oxo-6h-benzo[b][1]benzothiepine-2-carbonyl chloride Chemical compound S1C2=CC=CC=C2CC(=O)C2=CC=C(C(=O)Cl)C=C12 RJADSWKTSXTZJF-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
- 239000002841 Lewis acid Substances 0.000 description 3
- 239000005708 Sodium hypochlorite Substances 0.000 description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
- 206010000210 abortion Diseases 0.000 description 3
- 231100000176 abortion Toxicity 0.000 description 3
- 125000002252 acyl group Chemical group 0.000 description 3
- 201000009961 allergic asthma Diseases 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- KMAWVRYYKYVCNR-UHFFFAOYSA-N benzo[b][1]benzothiepine Chemical class C1=CC2=CC=CC=C2SC2=CC=CC=C21 KMAWVRYYKYVCNR-UHFFFAOYSA-N 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 229910000085 borane Inorganic materials 0.000 description 3
- 230000037020 contractile activity Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000012442 inert solvent Substances 0.000 description 3
- 239000013067 intermediate product Substances 0.000 description 3
- 150000007517 lewis acids Chemical class 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000002028 premature Effects 0.000 description 3
- 239000002089 prostaglandin antagonist Substances 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 150000003573 thiols Chemical class 0.000 description 3
- 239000004474 valine Substances 0.000 description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- JSRLURSZEMLAFO-UHFFFAOYSA-N 1,3-dibromobenzene Chemical compound BrC1=CC=CC(Br)=C1 JSRLURSZEMLAFO-UHFFFAOYSA-N 0.000 description 2
- XKFUZCKTRXZNCY-UHFFFAOYSA-N 1-bromo-3-[2-(bromomethyl)phenyl]sulfanylbenzene Chemical compound BrCC1=CC=CC=C1SC1=CC=CC(Br)=C1 XKFUZCKTRXZNCY-UHFFFAOYSA-N 0.000 description 2
- PIYVRCZYSFUNFN-UHFFFAOYSA-N 2,5-dibromo-5,6-dihydrobenzo[b][1]benzothiepine Chemical compound BrC1CC2=CC=CC=C2SC2=CC(Br)=CC=C12 PIYVRCZYSFUNFN-UHFFFAOYSA-N 0.000 description 2
- YGHWJUNGIXFXDS-UHFFFAOYSA-N 2-(5-oxo-6h-benzo[b][1]benzothiepin-2-yl)acetic acid Chemical compound S1C2=CC=CC=C2CC(=O)C2=CC=C(CC(=O)O)C=C12 YGHWJUNGIXFXDS-UHFFFAOYSA-N 0.000 description 2
- HQDKKCRFNPWOHC-UHFFFAOYSA-N 2-(bromomethyl)-1-(3-bromophenyl)sulfanyl-4-nitrobenzene Chemical compound BrCC1=CC([N+](=O)[O-])=CC=C1SC1=CC=CC(Br)=C1 HQDKKCRFNPWOHC-UHFFFAOYSA-N 0.000 description 2
- SIBNDMWAUZUKCJ-UHFFFAOYSA-N 2-[2-(3-bromophenyl)sulfanyl-5-nitrophenyl]acetonitrile Chemical compound N#CCC1=CC([N+](=O)[O-])=CC=C1SC1=CC=CC(Br)=C1 SIBNDMWAUZUKCJ-UHFFFAOYSA-N 0.000 description 2
- RHTQNXCRQCOMHU-UHFFFAOYSA-N 2-[2-(3-bromophenyl)sulfanylphenyl]acetic acid Chemical compound OC(=O)CC1=CC=CC=C1SC1=CC=CC(Br)=C1 RHTQNXCRQCOMHU-UHFFFAOYSA-N 0.000 description 2
- ICYMMGWYFUZPHM-UHFFFAOYSA-N 2-[2-(3-bromophenyl)sulfanylphenyl]acetonitrile Chemical compound BrC1=CC=CC(SC=2C(=CC=CC=2)CC#N)=C1 ICYMMGWYFUZPHM-UHFFFAOYSA-N 0.000 description 2
- YPBVNCOFWIUQCZ-UHFFFAOYSA-N 2-bromo-6h-benzo[b][1]benzothiepin-5-one Chemical compound S1C2=CC=CC=C2CC(=O)C2=CC=C(Br)C=C12 YPBVNCOFWIUQCZ-UHFFFAOYSA-N 0.000 description 2
- NUKJVKXGSMVAJO-UHFFFAOYSA-N 2-bromobenzo[b][1]benzothiepine Chemical compound C1=CC2=CC=CC=C2SC2=CC(Br)=CC=C21 NUKJVKXGSMVAJO-UHFFFAOYSA-N 0.000 description 2
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 2
- YTDHIEQRDBMUHF-UHFFFAOYSA-N 3-aminobenzo[b][1]benzothiepine-9-carbonitrile Chemical compound C1=CC2=CC(N)=CC=C2SC2=CC(C#N)=CC=C21 YTDHIEQRDBMUHF-UHFFFAOYSA-N 0.000 description 2
- HNGQQUDFJDROPY-UHFFFAOYSA-N 3-bromobenzenethiol Chemical compound SC1=CC=CC(Br)=C1 HNGQQUDFJDROPY-UHFFFAOYSA-N 0.000 description 2
- DHMXSGKMSIRKRI-UHFFFAOYSA-N 3-chlorobenzo[b][1]benzothiepine-9-carboxylic acid Chemical compound C1=CC2=CC(Cl)=CC=C2SC2=CC(C(=O)O)=CC=C21 DHMXSGKMSIRKRI-UHFFFAOYSA-N 0.000 description 2
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 2
- YMTRVMXXEIEMLP-UHFFFAOYSA-N 3-methyl-1,3-thiazolidin-2-imine Chemical class CN1CCSC1=N YMTRVMXXEIEMLP-UHFFFAOYSA-N 0.000 description 2
- NCKCWLRHTIBMNU-UHFFFAOYSA-N 3-nitrobenzo[b][1]benzothiepine-9-carbonitrile Chemical compound C1=CC2=CC([N+](=O)[O-])=CC=C2SC2=CC(C#N)=CC=C21 NCKCWLRHTIBMNU-UHFFFAOYSA-N 0.000 description 2
- OMKHDSLZTWOYQT-UHFFFAOYSA-N 3-nitrobenzo[b][1]benzothiepine-9-carboxylic acid Chemical compound C1=CC2=CC([N+]([O-])=O)=CC=C2SC2=CC(C(=O)O)=CC=C21 OMKHDSLZTWOYQT-UHFFFAOYSA-N 0.000 description 2
- KNTYHFZJYIQSJO-UHFFFAOYSA-N 3-sulfanylbenzo[b][1]benzothiepine-9-carboxylic acid Chemical compound C1=CC2=CC(S)=CC=C2SC2=CC(C(=O)O)=CC=C21 KNTYHFZJYIQSJO-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- FIQLHCSIVKQAAX-UHFFFAOYSA-N 4-(5-oxo-6h-benzo[b][1]benzothiepin-2-yl)-1,2,5-thiadiazol-3-one Chemical compound OC1=NSN=C1C1=CC=C2C(=O)CC3=CC=CC=C3SC2=C1 FIQLHCSIVKQAAX-UHFFFAOYSA-N 0.000 description 2
- XRNCAGUTIPEVSC-UHFFFAOYSA-N 5,11-dioxo-6h-benzo[b][1]benzothiepine-2-carbonitrile Chemical compound O=C1CC2=CC=CC=C2S(=O)C2=CC(C#N)=CC=C12 XRNCAGUTIPEVSC-UHFFFAOYSA-N 0.000 description 2
- VCFNIDRIXVXXMB-UHFFFAOYSA-N 5-benzo[b][1]benzothiepin-2-yl-2h-tetrazole Chemical compound C1=C2SC3=CC=CC=C3C=CC2=CC=C1C1=NN=NN1 VCFNIDRIXVXXMB-UHFFFAOYSA-N 0.000 description 2
- WBKUEQWZLFKCDX-UHFFFAOYSA-N 9-bromo-3-nitro-5,6-dihydrobenzo[b][1]benzothiepin-6-ol Chemical compound OC1CC2=CC([N+]([O-])=O)=CC=C2SC2=CC(Br)=CC=C12 WBKUEQWZLFKCDX-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- 206010027654 Allergic conditions Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 2
- SGUKUZOVHSFKPH-UHFFFAOYSA-N PGG2 Natural products C1C2OOC1C(C=CC(OO)CCCCC)C2CC=CCCCC(O)=O SGUKUZOVHSFKPH-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 239000007868 Raney catalyst Substances 0.000 description 2
- 229910000564 Raney nickel Inorganic materials 0.000 description 2
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 125000004422 alkyl sulphonamide group Chemical group 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- DFNYGALUNNFWKJ-UHFFFAOYSA-N aminoacetonitrile Chemical compound NCC#N DFNYGALUNNFWKJ-UHFFFAOYSA-N 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- WVDDGKGOMKODPV-UHFFFAOYSA-N benzyl alcohol Substances OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 2
- 230000031709 bromination Effects 0.000 description 2
- 238000005893 bromination reaction Methods 0.000 description 2
- OVIZSQRQYWEGON-UHFFFAOYSA-N butane-1-sulfonamide Chemical compound CCCCS(N)(=O)=O OVIZSQRQYWEGON-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 125000001589 carboacyl group Chemical group 0.000 description 2
- 150000003857 carboxamides Chemical class 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 150000001879 copper Chemical class 0.000 description 2
- 229960003280 cupric chloride Drugs 0.000 description 2
- 239000011928 denatured alcohol Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 150000001989 diazonium salts Chemical class 0.000 description 2
- WYACBZDAHNBPPB-UHFFFAOYSA-N diethyl oxalate Chemical compound CCOC(=O)C(=O)OCC WYACBZDAHNBPPB-UHFFFAOYSA-N 0.000 description 2
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 2
- WEHWNAOGRSTTBQ-UHFFFAOYSA-N dipropylamine Chemical compound CCCNCCC WEHWNAOGRSTTBQ-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- ZCRZCMUDOWDGOB-UHFFFAOYSA-N ethanesulfonimidic acid Chemical compound CCS(N)(=O)=O ZCRZCMUDOWDGOB-UHFFFAOYSA-N 0.000 description 2
- 239000012259 ether extract Substances 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 229960004275 glycolic acid Drugs 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 2
- HZTBIYLXNGVGHS-UHFFFAOYSA-N methyl 5,6-dihydrobenzo[b][1]benzothiepine-2-carboxylate Chemical compound C1CC2=CC=CC=C2SC2=CC(C(=O)OC)=CC=C21 HZTBIYLXNGVGHS-UHFFFAOYSA-N 0.000 description 2
- JSQPFBDLKKEVAH-UHFFFAOYSA-N methyl 5-oxo-6h-benzo[b][1]benzothiepine-2-carboxylate Chemical compound S1C2=CC=CC=C2CC(=O)C2=CC=C(C(=O)OC)C=C12 JSQPFBDLKKEVAH-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 150000002923 oximes Chemical class 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
- DROIHSMGGKKIJT-UHFFFAOYSA-N propane-1-sulfonamide Chemical compound CCCS(N)(=O)=O DROIHSMGGKKIJT-UHFFFAOYSA-N 0.000 description 2
- SGUKUZOVHSFKPH-YNNPMVKQSA-N prostaglandin G2 Chemical compound C1[C@@H]2OO[C@H]1[C@H](/C=C/[C@@H](OO)CCCCC)[C@H]2C\C=C/CCCC(O)=O SGUKUZOVHSFKPH-YNNPMVKQSA-N 0.000 description 2
- YIBNHAJFJUQSRA-YNNPMVKQSA-N prostaglandin H2 Chemical compound C1[C@@H]2OO[C@H]1[C@H](/C=C/[C@@H](O)CCCCC)[C@H]2C\C=C/CCCC(O)=O YIBNHAJFJUQSRA-YNNPMVKQSA-N 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 239000012047 saturated solution Substances 0.000 description 2
- 238000007493 shaping process Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 2
- 239000004296 sodium metabisulphite Substances 0.000 description 2
- 235000010262 sodium metabisulphite Nutrition 0.000 description 2
- 235000010288 sodium nitrite Nutrition 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000012258 stirred mixture Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- NBOMNTLFRHMDEZ-UHFFFAOYSA-N thiosalicylic acid Chemical class OC(=O)C1=CC=CC=C1S NBOMNTLFRHMDEZ-UHFFFAOYSA-N 0.000 description 2
- DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 description 2
- FWPIDFUJEMBDLS-UHFFFAOYSA-L tin(II) chloride dihydrate Chemical compound O.O.Cl[Sn]Cl FWPIDFUJEMBDLS-UHFFFAOYSA-L 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 1
- JTPOUDKPAGSBBA-QMMMGPOBSA-N (2s)-4-methyl-2-(propylamino)pentanoic acid Chemical compound CCCN[C@H](C(O)=O)CC(C)C JTPOUDKPAGSBBA-QMMMGPOBSA-N 0.000 description 1
- IHCWFFPGAOZJBF-IUCAKERBSA-N (2s,3s)-2-(butylamino)-3-methylpentanoic acid Chemical compound CCCCN[C@H](C(O)=O)[C@@H](C)CC IHCWFFPGAOZJBF-IUCAKERBSA-N 0.000 description 1
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 description 1
- PXGPLTODNUVGFL-BRIYLRKRSA-N (E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid Chemical compound CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=CCCCC(O)=O PXGPLTODNUVGFL-BRIYLRKRSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- QYOSCFSZAXIFJK-UHFFFAOYSA-N 11,11-dioxo-3-sulfanylbenzo[b][1]benzothiepine-9-carboxylic acid Chemical compound C1=CC2=CC(S)=CC=C2S(=O)(=O)C2=CC(C(=O)O)=CC=C21 QYOSCFSZAXIFJK-UHFFFAOYSA-N 0.000 description 1
- HBJAVTJETWGKGE-UHFFFAOYSA-N 11,11-dioxo-5,6-dihydrobenzo[b][1]benzothiepine-2-carbonitrile Chemical compound C1CC2=CC=C(C#N)C=C2S(=O)(=O)C2=CC=CC=C21 HBJAVTJETWGKGE-UHFFFAOYSA-N 0.000 description 1
- MGKWHVFUUWIIJD-UHFFFAOYSA-N 11,11-dioxobenzo[b][1]benzothiepine-2-carbonitrile Chemical compound C1=CC2=CC=C(C#N)C=C2S(=O)(=O)C2=CC=CC=C21 MGKWHVFUUWIIJD-UHFFFAOYSA-N 0.000 description 1
- PUTFCOPQNZLMAQ-UHFFFAOYSA-N 11-oxobenzo[b][1]benzothiepine-2-carbonitrile Chemical compound C1=CC2=CC=C(C#N)C=C2S(=O)C2=CC=CC=C21 PUTFCOPQNZLMAQ-UHFFFAOYSA-N 0.000 description 1
- KJUGUADJHNHALS-UHFFFAOYSA-N 1H-tetrazole Substances C=1N=NNN=1 KJUGUADJHNHALS-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- VLUNDKTVEVUVQU-UHFFFAOYSA-N 2-(2h-tetrazol-5-yl)benzo[b][1]benzothiepine 11-oxide Chemical compound C1=C2S(=O)C3=CC=CC=C3C=CC2=CC=C1C1=NN=NN1 VLUNDKTVEVUVQU-UHFFFAOYSA-N 0.000 description 1
- XCDGBJRMEFFYHX-UHFFFAOYSA-N 2-(3-bromophenyl)sulfanyl-5-nitrobenzoic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC=C1SC1=CC=CC(Br)=C1 XCDGBJRMEFFYHX-UHFFFAOYSA-N 0.000 description 1
- QAGLVHYLDHTEIT-UHFFFAOYSA-N 2-(5-oxo-6h-benzo[b][1]benzothiepin-2-yl)acetonitrile Chemical compound O=C1CC2=CC=CC=C2SC2=CC(CC#N)=CC=C12 QAGLVHYLDHTEIT-UHFFFAOYSA-N 0.000 description 1
- RLHGZQCOHWSIHJ-UHFFFAOYSA-N 2-(hydroxymethyl)-6h-benzo[b][1]benzothiepin-5-one Chemical compound S1C2=CC=CC=C2CC(=O)C2=CC=C(CO)C=C12 RLHGZQCOHWSIHJ-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- IHCCLXNEEPMSIO-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 IHCCLXNEEPMSIO-UHFFFAOYSA-N 0.000 description 1
- YSKHIYFADSEDSY-UHFFFAOYSA-N 2-bromo-5,6-dihydrobenzo[b][1]benzothiepin-5-ol Chemical compound OC1CC2=CC=CC=C2SC2=CC(Br)=CC=C12 YSKHIYFADSEDSY-UHFFFAOYSA-N 0.000 description 1
- RQLKLJWVUBVJOI-UHFFFAOYSA-N 2-bromo-5,6-dihydrobenzo[b][1]benzothiepine Chemical compound C1CC2=CC=CC=C2SC2=CC(Br)=CC=C21 RQLKLJWVUBVJOI-UHFFFAOYSA-N 0.000 description 1
- XRXMNWGCKISMOH-UHFFFAOYSA-N 2-bromobenzoic acid Chemical class OC(=O)C1=CC=CC=C1Br XRXMNWGCKISMOH-UHFFFAOYSA-N 0.000 description 1
- QUEKGYQTRJVEQC-UHFFFAOYSA-N 2516-96-3 Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC=C1Cl QUEKGYQTRJVEQC-UHFFFAOYSA-N 0.000 description 1
- ACFNDTWOHLHBJN-UHFFFAOYSA-N 3-acetyl-11,11-dioxo-5,6-dihydrobenzo[b][1]benzothiepine-9-carbonitrile Chemical compound C1CC2=CC=C(C#N)C=C2S(=O)(=O)C2=CC=C(C(=O)C)C=C12 ACFNDTWOHLHBJN-UHFFFAOYSA-N 0.000 description 1
- PLRHXRSKQZEJPJ-UHFFFAOYSA-N 3-acetyl-5,6-dihydrobenzo[b][1]benzothiepine-9-carbonitrile Chemical compound C1CC2=CC(C(=O)C)=CC=C2SC2=CC(C#N)=CC=C21 PLRHXRSKQZEJPJ-UHFFFAOYSA-N 0.000 description 1
- POVQCXMQRYFHBL-UHFFFAOYSA-N 3-amino-11,11-dioxobenzo[b][1]benzothiepine-9-carbonitrile Chemical compound C1=CC2=CC=C(C#N)C=C2S(=O)(=O)C2=CC=C(N)C=C21 POVQCXMQRYFHBL-UHFFFAOYSA-N 0.000 description 1
- UPOMDXUNPHLSES-UHFFFAOYSA-N 3-amino-5,6-dihydrobenzo[b][1]benzothiepine-9-carboxylic acid Chemical compound C1CC2=CC(N)=CC=C2SC2=CC(C(O)=O)=CC=C21 UPOMDXUNPHLSES-UHFFFAOYSA-N 0.000 description 1
- YCWYTMZHKJTPTR-UHFFFAOYSA-N 3-aminobenzo[b][1]benzothiepine-9-carboxylic acid Chemical compound C1=CC2=CC(N)=CC=C2SC2=CC(C(O)=O)=CC=C21 YCWYTMZHKJTPTR-UHFFFAOYSA-N 0.000 description 1
- VYBUQFYCXILSKF-UHFFFAOYSA-N 3-chlorobenzo[b][1]benzothiepine-9-carbonitrile Chemical compound C1=CC2=CC(Cl)=CC=C2SC2=CC(C#N)=CC=C21 VYBUQFYCXILSKF-UHFFFAOYSA-N 0.000 description 1
- DNOIWFQRHHMBAE-UHFFFAOYSA-N 3-hydroxy-11,11-dioxobenzo[b][1]benzothiepine-9-carboxylic acid Chemical compound C1=CC2=CC(O)=CC=C2S(=O)(=O)C2=CC(C(=O)O)=CC=C21 DNOIWFQRHHMBAE-UHFFFAOYSA-N 0.000 description 1
- HMBULLUZJZTAOY-UHFFFAOYSA-N 3-methoxy-11,11-dioxobenzo[b][1]benzothiepine-9-carboxylic acid Chemical compound C1=CC2=CC=C(C(O)=O)C=C2S(=O)(=O)C2=CC=C(OC)C=C21 HMBULLUZJZTAOY-UHFFFAOYSA-N 0.000 description 1
- NLMBUKMZMQHTNC-UHFFFAOYSA-N 3-methoxybenzo[b][1]benzothiepine-9-carboxylic acid Chemical compound C1=CC2=CC(OC)=CC=C2SC2=CC(C(O)=O)=CC=C21 NLMBUKMZMQHTNC-UHFFFAOYSA-N 0.000 description 1
- FKQRVFRZVYMYMF-UHFFFAOYSA-N 3-methylsulfinyl-11,11-dioxobenzo[b][1]benzothiepine-9-carboxylic acid Chemical compound C1=CC2=CC=C(C(O)=O)C=C2S(=O)(=O)C2=CC=C(S(=O)C)C=C21 FKQRVFRZVYMYMF-UHFFFAOYSA-N 0.000 description 1
- MMLLUVQNQQQOKM-UHFFFAOYSA-N 3-methylsulfonylbenzo[b][1]benzothiepine-9-carboxylic acid Chemical compound C1=CC2=CC(S(=O)(=O)C)=CC=C2SC2=CC(C(O)=O)=CC=C21 MMLLUVQNQQQOKM-UHFFFAOYSA-N 0.000 description 1
- YVZBINYGLQCKRH-UHFFFAOYSA-N 3-nitro-11,11-dioxobenzo[b][1]benzothiepine-9-carbonitrile Chemical compound C1=CC2=CC=C(C#N)C=C2S(=O)(=O)C2=CC=C([N+](=O)[O-])C=C21 YVZBINYGLQCKRH-UHFFFAOYSA-N 0.000 description 1
- VLBGVLTUPBXWFR-UHFFFAOYSA-N 3-nitro-11-oxobenzo[b][1]benzothiepine-9-carboxylic acid Chemical compound C1=CC2=CC([N+]([O-])=O)=CC=C2S(=O)C2=CC(C(=O)O)=CC=C21 VLBGVLTUPBXWFR-UHFFFAOYSA-N 0.000 description 1
- JVQIKJMSUIMUDI-UHFFFAOYSA-N 3-pyrroline Chemical compound C1NCC=C1 JVQIKJMSUIMUDI-UHFFFAOYSA-N 0.000 description 1
- YFHHNSBFQPPVCR-UHFFFAOYSA-N 4-(5,6-dihydrobenzo[b][1]benzothiepin-2-yl)-1,2,5-thiadiazol-3-one Chemical compound OC1=NSN=C1C1=CC=C(CCC=2C(=CC=CC=2)S2)C2=C1 YFHHNSBFQPPVCR-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- BPXBGSQTEQAOMO-UHFFFAOYSA-N 4-benzo[b][1]benzothiepin-2-yl-1,2,5-thiadiazol-3-one Chemical compound OC1=NSN=C1C1=CC=C(C=CC=2C(=CC=CC=2)S2)C2=C1 BPXBGSQTEQAOMO-UHFFFAOYSA-N 0.000 description 1
- MBVFRSJFKMJRHA-UHFFFAOYSA-N 4-fluoro-1-benzofuran-7-carbaldehyde Chemical compound FC1=CC=C(C=O)C2=C1C=CO2 MBVFRSJFKMJRHA-UHFFFAOYSA-N 0.000 description 1
- DBQYUWWOBWTUPV-UHFFFAOYSA-N 5,6-dihydrobenzo[b][1]benzothiepine Chemical compound C1CC2=CC=CC=C2SC2=CC=CC=C12 DBQYUWWOBWTUPV-UHFFFAOYSA-N 0.000 description 1
- JPDRYQSTXDSVND-UHFFFAOYSA-N 5,6-dihydrobenzo[b][1]benzothiepine-2-carboxamide Chemical compound C1CC2=CC=CC=C2SC2=CC(C(=O)N)=CC=C21 JPDRYQSTXDSVND-UHFFFAOYSA-N 0.000 description 1
- ZZPGEERLQYKIKA-UHFFFAOYSA-N 5-hydroxy-5,6-dihydrobenzo[b][1]benzothiepine-2-carboxylic acid Chemical compound OC1CC2=CC=CC=C2SC2=CC(C(O)=O)=CC=C12 ZZPGEERLQYKIKA-UHFFFAOYSA-N 0.000 description 1
- UMLPTICYFXEXOB-UHFFFAOYSA-N 5-oxo-6h-benzo[b][1]benzothiepine-2-carbaldehyde Chemical compound S1C2=CC=CC=C2CC(=O)C2=CC=C(C=O)C=C12 UMLPTICYFXEXOB-UHFFFAOYSA-N 0.000 description 1
- FKJPJCDTMFTYLB-UHFFFAOYSA-N 5-oxo-6h-benzo[b][1]benzothiepine-3-carbonyl chloride Chemical compound C1C(=O)C2=CC(C(=O)Cl)=CC=C2SC2=CC=CC=C21 FKJPJCDTMFTYLB-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- KYAHENURMDPYAE-UHFFFAOYSA-N 8-aminobenzo[d][1]benzothiepine-3-carbonitrile Chemical compound C12=CC=C(C#N)C=C2SC=CC2=C1C=CC=C2N KYAHENURMDPYAE-UHFFFAOYSA-N 0.000 description 1
- TXVDDKCVFSVMAT-UHFFFAOYSA-N 9-bromo-3-nitro-5h-benzo[b][1]benzothiepin-6-one Chemical compound O=C1CC2=CC([N+](=O)[O-])=CC=C2SC2=CC(Br)=CC=C21 TXVDDKCVFSVMAT-UHFFFAOYSA-N 0.000 description 1
- PHAVKCPGDNKQHN-UHFFFAOYSA-N 9-bromo-3-nitrobenzo[b][1]benzothiepine Chemical compound C1=CC2=CC([N+](=O)[O-])=CC=C2SC2=CC(Br)=CC=C21 PHAVKCPGDNKQHN-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- RZZPDXZPRHQOCG-OJAKKHQRSA-O CDP-choline(1+) Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OCC[N+](C)(C)C)O[C@H]1N1C(=O)N=C(N)C=C1 RZZPDXZPRHQOCG-OJAKKHQRSA-O 0.000 description 1
- LULGYFLCQWFPFB-UHFFFAOYSA-N CN1CCSC1=NC=O Chemical compound CN1CCSC1=NC=O LULGYFLCQWFPFB-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- 229910021592 Copper(II) chloride Inorganic materials 0.000 description 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 238000005727 Friedel-Crafts reaction Methods 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 201000001068 Prinzmetal angina Diseases 0.000 description 1
- 238000000297 Sandmeyer reaction Methods 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 238000005644 Wolff-Kishner reduction reaction Methods 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 description 1
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N alpha-methyl toluene Natural products CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000004648 butanoic acid derivatives Chemical class 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 125000005518 carboxamido group Chemical group 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 206010008129 cerebral palsy Diseases 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001804 chlorine Chemical class 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000007333 cyanation reaction Methods 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- 150000004683 dihydrates Chemical class 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- PXJJSXABGXMUSU-UHFFFAOYSA-N disulfur dichloride Chemical compound ClSSCl PXJJSXABGXMUSU-UHFFFAOYSA-N 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 208000024711 extrinsic asthma Diseases 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- BEBCJVAWIBVWNZ-UHFFFAOYSA-N glycinamide Chemical compound NCC(N)=O BEBCJVAWIBVWNZ-UHFFFAOYSA-N 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000003701 inert diluent Substances 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 125000002510 isobutoxy group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])O* 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- HQPKNWVDRICJMI-UHFFFAOYSA-N methyl 11-oxo-5,6-dihydrobenzo[b][1]benzothiepine-2-carboxylate Chemical compound C1CC2=CC=CC=C2S(=O)C2=CC(C(=O)OC)=CC=C21 HQPKNWVDRICJMI-UHFFFAOYSA-N 0.000 description 1
- XVMMZNQDQJCTOJ-UHFFFAOYSA-N methyl 5-bromo-5,6-dihydrobenzo[b][1]benzothiepine-2-carboxylate Chemical compound BrC1CC2=CC=CC=C2SC2=CC(C(=O)OC)=CC=C21 XVMMZNQDQJCTOJ-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000007932 molded tablet Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 150000004967 organic peroxy acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229960003424 phenylacetic acid Drugs 0.000 description 1
- 239000003279 phenylacetic acid Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- ZLMJMSJWJFRBEC-OUBTZVSYSA-N potassium-40 Chemical compound [40K] ZLMJMSJWJFRBEC-OUBTZVSYSA-N 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 150000004672 propanoic acids Chemical class 0.000 description 1
- 125000001325 propanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 150000005599 propionic acid derivatives Chemical class 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- AVXDKPABPXSLIZ-UHFFFAOYSA-M sodium;3-hydroxypropanoate Chemical compound [Na+].OCCC([O-])=O AVXDKPABPXSLIZ-UHFFFAOYSA-M 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000001119 stannous chloride Substances 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 125000001174 sulfone group Chemical group 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- BISQTCXKVNCDDA-UHFFFAOYSA-N thiepine Chemical compound S1C=CC=CC=C1 BISQTCXKVNCDDA-UHFFFAOYSA-N 0.000 description 1
- 229940103494 thiosalicylic acid Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
- C07D337/02—Seven-membered rings
- C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D337/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D337/14—[b,f]-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81919977A | 1977-07-26 | 1977-07-26 | |
| US91721278A | 1978-06-23 | 1978-06-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO782539L true NO782539L (no) | 1979-01-29 |
Family
ID=27124337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO782539A NO782539L (no) | 1977-07-26 | 1978-07-24 | Fremgangsmaate ved fremstilling av prostaglandinantagonistiske forbindelser |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0011067B1 (da) |
| JP (1) | JPS5444691A (da) |
| AR (2) | AR226527A1 (da) |
| AU (1) | AU517813B2 (da) |
| CA (1) | CA1128048A (da) |
| DD (1) | DD140746A5 (da) |
| DE (1) | DE2861754D1 (da) |
| DK (1) | DK330578A (da) |
| ES (5) | ES471871A1 (da) |
| FI (1) | FI782323A7 (da) |
| GR (1) | GR67276B (da) |
| IE (1) | IE47553B1 (da) |
| IT (1) | IT1107485B (da) |
| NO (1) | NO782539L (da) |
| PL (3) | PL117756B1 (da) |
| PT (1) | PT68303A (da) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4536507A (en) * | 1977-07-26 | 1985-08-20 | Merck & Co., Inc. | Prostaglandin antagonists |
| PT71280B (en) * | 1979-06-01 | 1981-09-17 | Merck & Co Inc | Process for preparing prostaglandin antagonists |
| DE3068250D1 (en) * | 1979-11-27 | 1984-07-19 | Merck Sharp & Dohme | 3-hydroxymethyldibenzo(b,f)thiepins and dibenzo(b,f)thiepin-3-carboxaldehydes as prostaglandin antagonists, process for their preparation and pharmaceutical compositions |
| US4237160A (en) * | 1979-11-27 | 1980-12-02 | Merck Sharp & Dohme (I.A.) Corp. | 3-Hydroxymethyldibenzo[b,f]thiepins as prostaglandin antagonists |
| NO811187L (no) * | 1980-11-24 | 1982-05-25 | Merck & Co Inc | Fremgangsmaate ved fremstilling av 7-fluor-dibenzo-(b,f)-thiepinderivater |
| US4535171A (en) * | 1982-11-18 | 1985-08-13 | Merck Frosst Canada, Inc. | Dibenzo[b,f]thiepin-3-carboxaldehydes as prostaglandin antagonists |
| US4622403A (en) * | 1983-10-11 | 1986-11-11 | Merck Frosst Canada, Inc. | 6-H dibenz[b,f]thiepin compounds |
| US4663347A (en) | 1983-10-31 | 1987-05-05 | Merck Frosst Canada, Inc. | Benzofuran 2-carboxylic acid esters useful as inhibitors of leukotriene biosynthesis |
| CA1309557C (en) | 1985-06-18 | 1992-10-27 | Robert N. Young | Leukotriene antagonists |
| ATE90076T1 (de) | 1986-03-27 | 1993-06-15 | Merck Frosst Canada Inc | Tetrahydrocarbazole ester. |
| US5428033A (en) | 1990-10-12 | 1995-06-27 | Merck Frosst Canada, Inc. | Saturated hydroxyalkylquinoline acids as leukotriene antagonists |
| US5410054A (en) * | 1993-07-20 | 1995-04-25 | Merck Frosst Canada, Inc. | Heteroaryl quinolines as inhibitors of leukotriene biosynthesis |
| WO1997025985A1 (en) | 1996-01-19 | 1997-07-24 | Nippon Suisan Kaisha, Ltd. | Tracheal smooth muscle relaxant |
| WO2000075127A1 (en) | 1999-06-03 | 2000-12-14 | Nippon Suisan Kaisha, Ltd. | Tricyclic fused heterocycle compounds, process for preparing the same and use thereof |
| TWI275495B (en) * | 2004-09-21 | 2007-03-11 | Sony Corp | Printer and printing method |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4101667A (en) * | 1975-05-30 | 1978-07-18 | Nippon Chemiphar Co., Ltd. | Benzo[b,f]thiepin derivatives |
| JPS5346989A (en) * | 1976-10-06 | 1978-04-27 | Nippon Chemiphar Co Ltd | Novel dibenzo(b,f)thiepin derivatives and their preparation |
| JPS6021156B2 (ja) * | 1976-12-03 | 1985-05-25 | 日本ケミフア株式会社 | ベンゾチエピン誘導体およびその製法 |
-
1978
- 1978-07-17 PT PT68303A patent/PT68303A/pt unknown
- 1978-07-19 IT IT50375/78A patent/IT1107485B/it active
- 1978-07-19 ES ES471871A patent/ES471871A1/es not_active Expired
- 1978-07-19 AU AU38177/78A patent/AU517813B2/en not_active Expired
- 1978-07-19 GR GR56820A patent/GR67276B/el unknown
- 1978-07-21 AR AR273031A patent/AR226527A1/es active
- 1978-07-21 DE DE7878300183T patent/DE2861754D1/de not_active Expired
- 1978-07-21 EP EP78300183A patent/EP0011067B1/en not_active Expired
- 1978-07-24 NO NO782539A patent/NO782539L/no unknown
- 1978-07-25 DD DD78206923A patent/DD140746A5/de unknown
- 1978-07-25 DK DK330578A patent/DK330578A/da not_active Application Discontinuation
- 1978-07-25 FI FI782323A patent/FI782323A7/fi not_active Application Discontinuation
- 1978-07-25 CA CA308,068A patent/CA1128048A/en not_active Expired
- 1978-07-25 IE IE1488/78A patent/IE47553B1/en unknown
- 1978-07-26 PL PL1978219619A patent/PL117756B1/pl unknown
- 1978-07-26 JP JP9054978A patent/JPS5444691A/ja active Granted
- 1978-07-26 PL PL1978225727A patent/PL120813B1/pl unknown
- 1978-07-26 PL PL1978208653A patent/PL116355B1/pl unknown
-
1979
- 1979-04-02 ES ES479217A patent/ES479217A1/es not_active Expired
- 1979-04-02 ES ES479216A patent/ES479216A1/es not_active Expired
- 1979-04-02 ES ES479218A patent/ES479218A1/es not_active Expired
- 1979-04-02 ES ES479215A patent/ES479215A1/es not_active Expired
- 1979-09-20 AR AR278140A patent/AR222666A1/es active
Also Published As
| Publication number | Publication date |
|---|---|
| ES471871A1 (es) | 1979-10-01 |
| IE47553B1 (en) | 1984-04-18 |
| CA1128048A (en) | 1982-07-20 |
| AR222666A1 (es) | 1981-06-15 |
| DD140746A5 (de) | 1980-03-26 |
| ES479217A1 (es) | 1979-07-01 |
| PL208653A1 (pl) | 1979-06-04 |
| IT7850375A0 (it) | 1978-07-19 |
| FI782323A7 (fi) | 1979-01-27 |
| IE781488L (en) | 1979-01-26 |
| EP0011067B1 (en) | 1982-04-21 |
| AU3817778A (en) | 1980-01-24 |
| JPS6250470B2 (da) | 1987-10-24 |
| DE2861754D1 (en) | 1982-06-03 |
| AR226527A1 (es) | 1982-07-30 |
| ES479215A1 (es) | 1979-07-01 |
| EP0011067A1 (en) | 1980-05-28 |
| PL120813B1 (en) | 1982-03-31 |
| DK330578A (da) | 1979-01-27 |
| JPS5444691A (en) | 1979-04-09 |
| IT1107485B (it) | 1985-11-25 |
| GR67276B (da) | 1981-06-26 |
| ES479218A1 (es) | 1979-11-01 |
| ES479216A1 (es) | 1979-07-01 |
| PL116355B1 (en) | 1981-06-30 |
| AU517813B2 (en) | 1981-08-27 |
| PL117756B1 (en) | 1981-08-31 |
| PT68303A (en) | 1978-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO782539L (no) | Fremgangsmaate ved fremstilling av prostaglandinantagonistiske forbindelser | |
| US4263207A (en) | 10,11-Dihydrodibenzo[b,f][1,4]thiazepine carboxylic acids esters and amides thereof | |
| US4282365A (en) | Dibenz[b,e]oxepin compounds | |
| AU759892B2 (en) | Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process | |
| US4237160A (en) | 3-Hydroxymethyldibenzo[b,f]thiepins as prostaglandin antagonists | |
| US4394515A (en) | 10,11-Dihydro-11-oxodibenzo[b,f]thiepin compounds | |
| US4536507A (en) | Prostaglandin antagonists | |
| US4582842A (en) | Anti-asthmatic 6H-dibenz-[b,e] [1,4]oxathiepin derivatives, compositions, and method of use therefor | |
| US4778897A (en) | 6H-dibenz[b,e][1,4]oxathiepin compounds | |
| EP0000978B1 (en) | 7-and 8-substituted -10,11-dihydro-11-oxodibenzo (b,f) thiepin derivatives, their production and their parmaceutical compositions | |
| US4699917A (en) | Anti-asthmatic tetrazolyl 6H-dibenz-[B,E]-[1,4]-oxathiepin derivatives, compositions, and method of use therefor | |
| EP0029587B1 (en) | 3-hydroxymethyldibenzo(b,f)thiepins and dibenzo(b,f)thiepin-3-carboxaldehydes as prostaglandin antagonists, process for their preparation and pharmaceutical compositions | |
| FI71733C (fi) | Foerfarande foer framstaellning av farmaceutiskt aktiva 3,6-substituerade 2-vinyl-kromoner. | |
| EP0052912B1 (en) | 7-fluoro-dibenzo(b,f)thiepin derivatives, their preparation and resolution, and compositions containing them | |
| DK159110B (da) | 4h-benzo(4,5)cyclohepta(1,2-b)thiophenderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende derivaterne | |
| EP0069810B1 (en) | Novel dibenzoxepins, their preparation, compositions containing them and the use of dibenzoxepins in the treatment of allergic conditions | |
| US4622403A (en) | 6-H dibenz[b,f]thiepin compounds | |
| EP0023078B1 (en) | Substituted dibenzo(b,f)thiepin-3-carboxylic acid derivatives, their preparation and pharmaceutical compositions containing them | |
| US4472586A (en) | 6H-Dibenz[b,e][1,4]oxathiepin derivatives | |
| CA1208653A (en) | 6h-dibenz [b,e] [1,4] oxathiepin derivatives | |
| JPH0250906B2 (da) | ||
| US4535171A (en) | Dibenzo[b,f]thiepin-3-carboxaldehydes as prostaglandin antagonists | |
| EP0157963A1 (en) | 6H-dibenz (b,e)(1,4)oxathiepin compounds | |
| CA1230124A (en) | 6h-dibenz[b,e][1,4]oxathiepin compounds | |
| IE52690B1 (en) | Novel dibenzoxepins,their preparation,compositions containing them and the use of dibenzoxepins in the treatment of allergic conditions |